Choosing the Right Gene Target for Microbial Identification

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Choose 16S rRNA gene sequencing for routine bacterial identification when genus-level or species-group resolution meets your diagnostic need and you require broad database support.
Select ITS region sequencing for fungal identification, and reserve multi-locus housekeeping gene analysis for cases needing species-level discrimination among closely related bacteria.
No single genetic marker resolves every microbe, so match marker choice to your sample type, expected organism, required resolution, and available reference databases.

The Core Problem in Microbial Identification

Microbial identification has moved beyond culture morphology and biochemical panels. Molecular methods now anchor modern microbiology laboratories, yet the choice of genetic target determines whether an identification is reliable, reproducible, and clinically or industrially useful. The 16S rRNA gene, the internal transcribed spacer (ITS) region, and housekeeping genes each offer distinct strengths and weaknesses. Selecting the wrong target can produce ambiguous results, misidentify closely related species, or waste laboratory resources on repeated sequencing runs.

The decision matters across food safety, clinical diagnostics, environmental monitoring, and quality control. Official methods such as the FDA Bacteriological Analytical Manual rely on validated molecular approaches for foodborne pathogen detection and characterization. The American Society for Microbiology provides professional guidance on laboratory practice and workforce expectations. Understanding the genetic basis of identification is therefore not an academic exercise but a practical requirement for laboratory professionals.

The Genetic Markers Compared

16S rRNA Gene

The 16S ribosomal RNA gene is the most widely used molecular marker for bacterial identification. It is present in all bacteria and archaea, contains conserved regions that allow universal primer binding, and includes variable regions that provide taxonomic discrimination. The gene is approximately 1,500 base pairs long and is organized into nine variable regions interspersed with conserved sequences.

The primary advantage of 16S rRNA is its universality. A single set of primers can amplify the gene from nearly any bacterial species, making it the default first-line marker for unknown isolates. Public databases contain hundreds of thousands of 16S sequences, providing broad coverage for comparison. The gene is also stable within a species, which supports reproducible identifications across laboratories.

The main limitation is resolution. The 16S rRNA gene cannot reliably distinguish between closely related species, particularly within genera such as Bacillus, Clostridium, and Streptococcus. In these groups, different species may share 99 percent or more sequence identity in the 16S gene. Full-length sequencing improves resolution compared with partial sequencing, but even complete 16S sequences may not separate all species.

ITS Region

The internal transcribed spacer region is the standard marker for fungal identification. The ITS region is located between the small subunit and large subunit ribosomal RNA genes and is transcribed but not incorporated into the mature ribosome. It evolves faster than the rRNA genes themselves, providing greater discrimination among closely related fungal species.

ITS sequencing is the recommended barcode for fungi because it combines high copy number, conserved flanking regions for primer binding, and sufficient variability for species-level discrimination. The region is approximately 500 to 800 base pairs in most fungi, and the ITS1 and ITS2 subregions are often analyzed separately or together.

The limitation of ITS is that it does not resolve all fungal species. Some species complexes, such as those within Aspergillus and Fusarium, require additional markers for accurate identification. ITS also has limited utility for bacteria, which do not possess the same ribosomal organization.

Housekeeping Genes

Housekeeping genes encode proteins essential for basic cellular functions and are present in all organisms. Examples include the genes for RNA polymerase subunits, DNA gyrase, and elongation factors. These genes evolve more slowly than ITS but faster than the rRNA genes, and they provide higher resolution than 16S rRNA for closely related bacterial species.

Multi-locus sequence analysis uses multiple housekeeping genes to achieve species-level resolution. This approach is standard for organisms where 16S rRNA is insufficient, such as the Burkholderia cepacia complex, the Bacillus cereus group, and many environmental bacteria. The method requires sequencing several genes, typically five to seven, and comparing the concatenated sequences against reference databases.

The tradeoff is cost and complexity. Multi-locus analysis requires more sequencing reactions, more bioinformatics, and more curated reference data. It is not a practical first-line method for routine identification but is essential for accurate species assignment in clinically or industrially important groups.

At a Glance: Marker Selection Table

Marker	Target Organisms	Resolution	Universality	Database Coverage	Relative Cost	Best Use
16S rRNA gene	Bacteria	Genus to species, limited for close relatives	High, present in all bacteria	Extensive	Low to moderate	First-line bacterial identification
ITS region	Fungi	Species level for most fungi	High for fungi, absent in bacteria	Extensive for fungi	Low to moderate	Fungal species identification
Housekeeping genes	Bacteria and fungi	Species to strain level	Moderate, requires multiple genes	Variable, curated	High	Closely related species, multi-locus analysis

Decision Framework for Marker Selection

Step 1: Define the Organism Group

The first decision is whether the unknown organism is likely bacterial or fungal. Gram stain, colony morphology, and growth characteristics provide initial clues. If the organism is bacterial, the 16S rRNA gene is the default first-line marker. If the organism is fungal, the ITS region is the appropriate starting point.

Step 2: Assess Required Resolution

Consider the diagnostic question. Is genus-level identification sufficient, or is species-level identification required for clinical, regulatory, or quality purposes? For routine environmental monitoring, genus-level identification may be adequate. For clinical isolates or food safety investigations, species-level identification is often necessary.

Step 3: Evaluate Database Coverage

The accuracy of sequence-based identification depends on the quality and completeness of reference databases. The American Type Culture Collection maintains authenticated biological materials and strain information that support reliable comparisons. When a species is poorly represented in databases, sequence-based identification may produce ambiguous results.

Step 4: Consider Cost and Turnaround Time

Full-length 16S sequencing is more expensive than partial sequencing but provides better resolution. Multi-locus analysis is the most expensive and time-consuming option. Laboratories must balance the cost of identification against the consequences of an incorrect result.

Step 5: Confirm with Phenotypic Methods

Molecular identification should be confirmed with phenotypic methods when possible. Biochemical tests, serotyping, and antimicrobial susceptibility testing provide complementary information. The Clinical and Laboratory Standards Institute provides standards-based antimicrobial susceptibility testing guidance that supports the clinical interpretation of identified isolates.

Practical Workflow for Marker Selection

The following workflow guides the selection of a genetic marker for an unknown isolate.

Perform initial characterization with Gram stain, colony morphology, and culture conditions.
Determine whether the organism is bacterial or fungal.
For bacteria, extract DNA and amplify the 16S rRNA gene with universal primers.
For fungi, extract DNA and amplify the ITS region with fungal-specific primers.
Sequence the amplified product and compare the sequence against a curated reference database.
Evaluate the quality of the match, including percent identity and query coverage.
If the identification is ambiguous or the percent identity is below the threshold for species-level assignment, consider multi-locus housekeeping gene analysis.
Confirm the identification with phenotypic tests when appropriate.
Document the identification method, the reference database, and the quality metrics in the laboratory record.

Records and Measurements

Accurate identification requires careful documentation of the sequence and the analysis parameters. The laboratory record should include the following:

The source of the isolate and the date of isolation
The DNA extraction method and the quality of the extracted DNA
The primers used for amplification and the PCR conditions
The sequence obtained and the length of the high-quality sequence
The reference database used and the version or date of the database
The percent identity and query coverage for the top match
The interpretation of the result, including any limitations

The percent identity threshold for species-level identification varies by organism and database. A common threshold is 98.7 percent for the 16S rRNA gene, but this threshold is not universal. The laboratory should establish its own thresholds based on the organism group and the reference database.

Common Failure Patterns

Ambiguous Identification

The most common failure is an ambiguous identification where the sequence matches multiple species with equal or nearly equal identity. This pattern occurs when the marker lacks sufficient resolution to separate closely related species. The solution is to use a higher-resolution marker or to perform multi-locus analysis.

Database Gaps

A sequence may have no close match in the reference database. This pattern occurs with novel or rare species. The result should be reported as the closest match with a note that the identification is not definitive. The sequence should be submitted to a public database to improve future identifications.

Contamination

Contamination can produce mixed sequences or sequences from the contaminant instead of the target organism. The laboratory should use appropriate controls, including a negative control and a positive control, to detect contamination. The American Type Culture Collection provides authenticated strains that can serve as positive controls.

Primer Mismatches

Primer mismatches can cause amplification failure or biased amplification. The laboratory should verify that the primers are appropriate for the target organism group and that the amplification conditions are optimized.

Quality Controls and Standards

Quality control is essential for reliable molecular identification. The laboratory should use:

A negative control to detect reagent contamination
A positive control with a known organism to verify the amplification and sequencing process
A reference strain from a culture collection to verify the database comparison
Replicate samples to assess reproducibility

The American Type Culture Collection provides authenticated biological materials that are suitable for quality control. The use of authenticated strains ensures that the reference sequences are correct and that the identification process is reliable.

Biosafety and Containment

Molecular identification involves the handling of microbial cultures and DNA extraction. The laboratory must follow biosafety principles for the containment of the organisms being processed. The CDC and NIH provide guidance on biosafety in microbiological and biomedical laboratories, including risk assessment, containment, and decontamination procedures.

The biosafety level of the laboratory should match the risk group of the organisms being handled. Organisms that are known to cause disease in healthy adults require higher containment levels. The laboratory should conduct a risk assessment before handling any isolate and should follow the appropriate decontamination procedures for waste and equipment.

Antimicrobial Resistance Context

The identification of an organism is the first step in the management of antimicrobial resistance. The World Health Organization defines antimicrobial resistance as the ability of a microorganism to resist the effects of drugs that were previously effective against it. Accurate species identification is necessary for the selection of appropriate antimicrobial susceptibility testing and for the interpretation of resistance patterns.

The Clinical and Laboratory Standards Institute provides standards-based methods for antimicrobial susceptibility testing. These methods are used to determine the susceptibility of an identified isolate to antimicrobial agents. The results of susceptibility testing are used to guide treatment decisions and to monitor the emergence of resistance.

Limitations of Molecular Identification

Molecular identification is a powerful tool, but it has limitations. The accuracy of the identification depends on the quality of the reference database, the resolution of the marker, and the quality of the sequence. The laboratory should be aware of these limitations and report the results with appropriate caveats.

The identification of a species does not provide information about the phenotype of the organism. Two isolates of the same species may differ in their biochemical characteristics, their antimicrobial susceptibility, or their ability to cause disease. Molecular identification should be combined with phenotypic testing for a complete characterization.

Professional Escalation Criteria

The laboratory should escalate the identification to a higher level of expertise in the following situations:

The sequence quality is poor and cannot be improved by repeated sequencing
The identification is ambiguous and the multi-locus analysis is not available
The organism is a known pathogen and the identification is critical for patient care
The organism is a novel species and the identification requires expert taxonomic review
The identification is inconsistent with the phenotypic characteristics of the organism

In these situations, the laboratory should consult with a clinical microbiologist, a reference laboratory, or a taxonomic expert.

Building a Marker Validation and Troubleshooting Protocol for Your Laboratory

Selecting a genetic marker is only the first decision. The second decision, which laboratories often overlook, is how to validate that the chosen marker performs correctly in your specific hands, with your specific samples, and against your specific reference databases. A marker that works well in a published study may fail in your laboratory because of differences in DNA extraction methods, primer batches, thermal cycler performance, or the quality of the reference sequences you use for comparison. This section provides a practical validation protocol, a record system for tracking marker performance, and a troubleshooting method for the most common failures that occur after marker selection.

Why Validation Matters Before Routine Use

The American Society for Microbiology emphasizes that laboratory professionals must understand the principles behind their methods and verify that those methods work in their own context. A genetic marker is not a fixed tool with guaranteed performance. It is a biological assay that depends on the interaction between the primers, the polymerase, the extraction method, and the target organism. Each of these components can vary between laboratories and even between runs within the same laboratory.

Validation is the process of demonstrating that a marker produces accurate, reproducible results for the intended use. Without validation, you cannot know whether a 98.7 percent sequence match to a reference strain represents a true species-level identification or an artifact of your specific conditions. The FDA Bacteriological Analytical Manual provides a useful model for this thinking. Official methods for foodborne pathogen detection include detailed validation steps, including testing against known reference strains, assessing sensitivity and specificity, and documenting performance characteristics. Your laboratory should apply the same rigor to any marker you adopt, even if the marker is not part of an official method.

Validation also protects against the cost of repeated sequencing runs. A marker that fails to amplify, produces mixed sequences, or generates ambiguous matches will consume reagents, technician time, and instrument capacity. A validation protocol that identifies these problems before you process clinical or food samples will save resources and prevent the frustration of uninterpretable results.

Step 1: Establish a Reference Panel

The first step in validation is to assemble a panel of reference organisms that represent the range of microbes you expect to identify. The American Type Culture Collection provides authenticated biological materials with documented strain information. These authenticated strains are essential because they give you a known answer against which to compare your results. If you sequence a reference strain and the result does not match the documented sequence, you know that your marker or your process has a problem.

Your reference panel should include at least three categories of organisms. The first category is the target organisms you expect to identify most often. If you work with food samples, include the common foodborne pathogens and spoilage organisms. If you work with clinical samples, include the common clinical isolates. The second category is closely related organisms that are difficult to distinguish. These are the organisms that test the resolution of your marker. If your marker cannot separate these organisms, you need to know that before you encounter them in a real sample. The third category is a negative control organism that should not amplify with your primers. This organism tests the specificity of your primers and detects cross-reactivity.

For each reference organism, you need a documented sequence. The American Type Culture Collection provides sequence information for many of its strains. You can also generate your own reference sequences by sequencing the organism with a different marker or by using a published sequence from a peer-reviewed study. The key is that the reference sequence must be trustworthy. If you are not sure about the sequence, you cannot use it to validate your marker.

Step 2: Test the Marker Against the Reference Set

Once you have assembled the reference panel, you test the marker against each organism. The test should include the full workflow that you will use for real samples, including DNA extraction, amplification, sequencing, and database comparison. You should not skip any step or use a simplified version of the workflow. The purpose of validation is to test the actual process you will use.

For each reference organism, record the following data:

The organism name and strain identifier
The source of the reference sequence
The DNA extraction method and the quality of the extracted DNA
The primers used and the amplification conditions
The sequence obtained and the length of the high-quality sequence
The percent identity and query coverage for the top match
The interpretation of the result

The interpretation should include whether the result matches the expected identification. If the result does not match, you have identified a validation failure that must be resolved before you use the marker for real samples.

Step 3: Assess Reproducibility

Reproducibility is the ability of the marker to produce the same result when the same sample is processed multiple times. This is a critical validation step because it tests the stability of your workflow. A marker that produces different results on different runs is not reliable, even if the results are correct each time.

To assess reproducibility, process the same reference organism at least three times on different days. Use the same extraction method, the same primers, and the same sequencing approach. Record the sequence and the identification for each run. The results should be identical or nearly identical. If the results vary, you need to identify the source of the variation. The variation could come from the extraction, the amplification, the sequencing, or the database comparison.

Reproducibility testing also includes the assessment of the sequence quality. The sequence quality should be consistent across runs. If the sequence quality varies, you may have a problem with the amplification or the sequencing that needs to be addressed.

Step 4: Assess the Database Comparison

The database comparison is the final step in the identification process. The accuracy of the comparison depends on the quality and completeness of the reference database. The American Type Culture Collection provides authenticated biological materials and strain information that support reliable comparisons. The database should be curated, comprehensive, and appropriate for the organism group.

During validation, you should test the database comparison with your reference sequences. The comparison should produce the expected identification for each reference organism. If the database does not produce the expected identification, you have a database problem. The database may be missing the reference sequence, or the reference sequence may be incorrect.

You should also test the database comparison with a sequence that is not in the database. This tests the behavior of the database when it encounters a novel or rare sequence. The database should produce a closest match with a note that the identification is not definitive. If the database produces a definitive identification for a sequence that is not in the database, the database is not reliable.

Step 5: Establish Acceptance Criteria

The validation protocol should include acceptance criteria that define what constitutes a successful validation. The acceptance criteria should be based on the performance of the marker with the reference panel. The criteria should include:

The percentage of reference organisms that produce the expected identification
The minimum sequence quality score
The minimum percentage identity for a species-level identification
The maximum number of ambiguous identifications

The acceptance criteria should be realistic and based on the known performance of the marker. For example, if the marker is known to have limited resolution for a particular group, the acceptance criteria should reflect that limitation. The criteria should be documented and used to evaluate the validation results.

The Validation Record

The validation record is the documentation of the validation process. It should include all the data from the reference panel, the reproducibility testing, and the database comparison. The record should also include the acceptance criteria and the interpretation of the results.

The validation record should be stored in a location that is accessible to all laboratory personnel. It should be reviewed and updated whenever the marker, the primers, the database, or the workflow changes. The record should also be reviewed when a new organism group is added to the laboratory's scope.

The validation record is not a one-time document. It is a living document that should be updated as the laboratory gains experience with the marker. The record should include a log of any problems encountered during routine use and the resolution of those problems. This log provides a history of the marker's performance and helps to identify patterns of failure.

Troubleshooting a Failed Validation

When a validation fails, the first step is to identify the source of the failure. The failure could come from the reference organism, the extraction, the amplification, the sequencing, or the database comparison. The troubleshooting method should be systematic and should isolate each step of the workflow.

Reference Organism Failure

If the reference organism does not produce the expected sequence, the first step is to verify the identity of the reference organism. The American Type Culture Collection provides authenticated strains, but the strain may have been mislabeled or contaminated during storage. The reference organism should be re-cultured and re-identified using a different method, such as biochemical testing or a different genetic marker.

Extraction Failure

If the extraction fails, the DNA may be degraded, or the extraction may not have been performed correctly. The DNA quality should be assessed using a spectrophotometer or a fluorometer. The DNA should be of sufficient quality and quantity for the amplification. If the DNA is degraded, the extraction should be repeated with a fresh sample.

Amplification Failure

If the amplification fails, the primers may not be appropriate for the organism, or the amplification conditions may not be optimized. The primers should be checked for compatibility with the target organism. The amplification conditions should be checked for the correct annealing temperature, extension time, and cycle number. The amplification should be repeated with a positive control to verify that the PCR is working.

Sequencing Failure

If the sequencing fails, the sequence may be of poor quality, or the sequencing reaction may not have been performed correctly. The sequencing should be repeated with a fresh reaction. The sequence quality should be assessed using the quality scores provided by the sequencing instrument. If the sequence quality is poor, the sequencing should be repeated with a different primer or a different sequencing approach.

Database Comparison Failure

If the database comparison fails, the database may not contain the reference sequence, or the database may contain an incorrect sequence. The database should be checked for the presence of the reference sequence. If the reference sequence is not in the database, the database should be updated. If the reference sequence is in the database but the comparison does not produce the expected result, the database may contain an incorrect sequence.

Common Validation Failure Patterns

The following are common validation failure patterns and their likely causes.

Pattern 1: The Reference Organism Produces an Unexpected Identification

This pattern occurs when the reference organism is not the organism that was expected. The cause is usually a mislabeled or contaminated reference organism. The solution is to verify the identity of the reference organism using a different method.

Pattern 2: The Reference Organism Produces a Low-Quality Sequence

This pattern occurs when the sequence quality is below the acceptance criteria. The cause is usually a problem with the extraction or the sequencing. The solution is to repeat the extraction or the sequencing with a fresh sample.

Pattern 3: The Reference Organism Produces a Sequence That Does Not Match the Database

This pattern occurs when the sequence does not match any sequence in the database. The cause is usually a database gap or an incorrect database sequence. The solution is to update the database or to use a different database.

Pattern 4: The Reference Organism Produces a Sequence That Matches the Wrong Species

This pattern occurs when the sequence matches a species that is not the expected species. The cause is usually a lack of resolution in the marker or an incorrect database sequence. The solution is to use a higher-resolution marker or to check the database sequence.

The Role of the Validation in Routine Use

The validation protocol is not a one-time activity. It should be repeated whenever the marker, the primers, the database, or the workflow changes. It should also be repeated when the laboratory introduces a new organism group or a new sample type.

The validation record should be reviewed periodically to identify patterns of failure. If a pattern of failure is identified, the laboratory should investigate the cause and take corrective action. The corrective action may include changing the marker, changing the primers, updating the database, or changing the workflow.

The validation record also provides a basis for the professional escalation criteria. If a validation failure cannot be resolved, the laboratory should escalate the issue to a higher level of expertise. The escalation may include consulting with a clinical microbiologist, a reference laboratory, or a taxonomic expert.

Biosafety Considerations During Validation

The validation protocol involves the handling of microbial cultures and DNA extraction. The laboratory must follow biosafety principles for the containment of the organisms being processed. The CDC and NIH provide guidance on biosafety in microbiological and biomedical laboratories, including risk assessment, containment, and decontamination procedures.

The validation protocol should include the same biosafety measures as the routine identification workflow. The reference organisms should be handled with the same level of containment as the samples that will be processed in routine use. The validation should not be performed in a lower containment level than the routine workflow.

The Validation and the Antimicrobial Resistance Context

The validation protocol is also relevant to the antimicrobial resistance context. The World Health Organization defines antimicrobial resistance as the ability of a microorganism to resist the effects of drugs that were previously effective against it. Accurate species identification is necessary for the selection of appropriate antimicrobial susceptibility testing and for the interpretation of resistance patterns.

The validation protocol ensures that the species identification is accurate. If the species identification is inaccurate, the antimicrobial susceptibility testing may be performed on the wrong species, and the results may be misinterpreted. The validation protocol is therefore a critical component of the antimicrobial resistance surveillance and stewardship.

The Clinical and Laboratory Standards Institute provides standards-based methods for antimicrobial susceptibility testing. These methods are used to determine the susceptibility of an identified isolate to antimicrobial agents. The validation protocol ensures that the identification is accurate, which supports the correct interpretation of the susceptibility testing results.

Professional Escalation Criteria for Validation Failures

The laboratory should escalate the validation failure to a higher level of expertise in the following situations:

The validation failure cannot be resolved after repeated attempts
The validation failure is due to a database issue that cannot be corrected
The validation failure is due to a marker limitation that cannot be overcome
The validation failure is due to a biosafety concern that requires expert review
The validation failure is due to a novel organism that requires taxonomic review

In these situations, the laboratory should consult with a clinical microbiologist, a reference laboratory, or a taxonomic expert. The escalation should be documented in the validation record.

The Validation Record as a Quality Control Tool

The validation record is a quality control tool that supports the reliability of the identification process. It provides a documented basis for the interpretation of the results and for the escalation of failures. The record should be reviewed by the laboratory supervisor or the quality manager on a regular basis.

The validation record should also be used to train new laboratory personnel. The record provides a practical example of the validation process and the troubleshooting method. The new personnel can use the record to understand the expected performance of the marker and the steps to take when the marker fails.

The validation record is a living document that should be updated as the laboratory gains experience with the marker. The record should include the validation data, the troubleshooting results, and the corrective actions. The record should be reviewed and updated at least annually or whenever the marker, the primers, the database, or the workflow changes.

Summary of the Validation Protocol

The validation protocol is a practical method for ensuring that a genetic marker performs correctly in your laboratory. The protocol includes the following steps:

Establish a reference set of authenticated organisms
Test the marker against the reference set
Document the results and the interpretation
Assess the reproducibility of the marker
Test the database comparison
Establish acceptance criteria
Document the validation in a record
Troubleshoot any validation failures
Escalate unresolved failures to a higher level of expertise

The validation protocol is a critical component of the marker selection process. It ensures that the marker is also selected correctly but also performs correctly in your specific context. The validation record provides a documented basis for the interpretation of the marker and for the quality control of the laboratory.

Frequently Asked Questions

What is the difference between 16S rRNA and ITS?

The 16S rRNA gene is a ribosomal RNA gene found in all bacteria and is used for bacterial identification. The ITS region is a non-coding region between the ribosomal RNA genes and is used for fungal identification. The two markers are not interchangeable.

Can the 16S rRNA gene identify all bacteria?

The 16S rRNA gene can identify most bacteria to the genus level and many to the species level. It cannot distinguish between some closely related species, and the resolution depends on the organism group and the quality of the reference database.

When should I use multi-locus housekeeping gene analysis?

Multi-locus housekeeping gene analysis is appropriate when the 16S rRNA gene does not provide sufficient resolution for species-level identification. It is used for closely related species groups and for organisms where species-level identification is critical.

How do I choose the right reference database?

The reference database should be curated, comprehensive, and appropriate for the organism group. The database should be updated regularly, and the laboratory should document the version used for each identification.

What is the minimum percent identity for species-level identification?

The minimum percent identity for species-level identification varies by organism and gene. A common threshold for the 16S rRNA gene is 98.7 percent, but this threshold is not universal. The laboratory should establish its own thresholds based on the organism group and the database.

How do I handle an ambiguous identification?

An ambiguous identification occurs when the sequence matches multiple species with equal or nearly equal identity. The laboratory should report the closest match with a note that the identification is not definitive and consider multi-locus analysis for resolution.

What are the biosafety considerations for molecular identification?

The laboratory must follow biosafety principles for the containment of the organisms being handled. The biosafety level should match the risk of the organism, and the laboratory should follow the guidance of the CDC and NIH for biosafety in microbiological and biomedical laboratories.

How does molecular identification relate to antimicrobial resistance?

Molecular identification provides the species identity that is necessary for the correct interpretation of antimicrobial susceptibility testing. The World Health Organization defines antimicrobial resistance and provides context for the global response to resistance.

Using the Evidence

Source	Best use in this topic	Important limitation
Biosafety in Microbiological and Biomedical Laboratories	official guidance	Check the linked page for current local requirements
Microbiology Resources	official guidance	Check the linked page for current local requirements
Antimicrobial Resistance	official guidance	Check the linked page for current local requirements

Related Diagnostic Guides

References and Further Reading

Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
Microbiology Resources. American Society for Microbiology.
Antimicrobial Resistance. World Health Organization.
Bacteriological Analytical Manual. U.S. Food and Drug Administration.
Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
Culture Collections. American Type Culture Collection.
Laboratory Biosafety Manual. World Health Organization.
NCBI Literature Resources. National Center for Biotechnology Information.
Identification of mycobacteria species by molecular methods.. International wound journal, 2020.
Comparison of nine extraction methods for bacterial identification using the ONT MinION sequencer.. International journal of legal medicine, 2024.
Evaluation of phenotypic and molecular methods for identification of Streptococcus pneumoniae.. Future microbiology, 2016.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.